What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.

BACKGROUND: The outcome measures most frequently used in studies on the effectiveness of migraine treatment are whether the patient is free of pain, nausea, and free of photophobia/phonophobia within two hours. However, no patient-centred outcome measures are available. Therefore, we performed an on...

Full description

Bibliographic Details
Main Authors: Antonia F H Smelt, Mark A Louter, Dennis A Kies, Jeanet W Blom, Gisela M Terwindt, Geert J M G van der Heijden, Véronique De Gucht, Michel D Ferrari, Willem J J Assendelft
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4059644?pdf=render
_version_ 1818943032678940672
author Antonia F H Smelt
Mark A Louter
Dennis A Kies
Jeanet W Blom
Gisela M Terwindt
Geert J M G van der Heijden
Véronique De Gucht
Michel D Ferrari
Willem J J Assendelft
author_facet Antonia F H Smelt
Mark A Louter
Dennis A Kies
Jeanet W Blom
Gisela M Terwindt
Geert J M G van der Heijden
Véronique De Gucht
Michel D Ferrari
Willem J J Assendelft
author_sort Antonia F H Smelt
collection DOAJ
description BACKGROUND: The outcome measures most frequently used in studies on the effectiveness of migraine treatment are whether the patient is free of pain, nausea, and free of photophobia/phonophobia within two hours. However, no patient-centred outcome measures are available. Therefore, we performed an online Delphi procedure to compile a list of outcome measures deemed most important to migraine patients. METHODS: From a large database of migraine patients, we randomly selected 150 males and 150 females patients. We asked the open-ended question: 'If a new medicine was developed for migraine attacks, what would you wish the effect of this medication to be?' In the second and third rounds, we presented the answers of the first round and asked the patients to rate the importance of each item. RESULTS: The initial response rate was 56% (n = 169). In the subsequent rounds the response rates were 90% (n = 152), and 97% (n = 147), respectively. Patients wanted their attack medication to treat the headache within 30 min, to prevent the attack from getting worse, to ensure they could function properly within 1 h, and prevent the recurrence of symptoms during the same day. CONCLUSIONS: The currently used outcome measures in migraine research do not sufficiently reflect the wishes of patients. Patients want the medication to work faster, to take away pain at an earlier stage, to make them able to function properly quickly, and to prevent recurrence. These aspects should be considered in future evaluation of new attack medication for migraine.
first_indexed 2024-12-20T07:20:53Z
format Article
id doaj.art-dec72e422cf1403dba4964075c256d5d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T07:20:53Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-dec72e422cf1403dba4964075c256d5d2022-12-21T19:48:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e9893310.1371/journal.pone.0098933What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.Antonia F H SmeltMark A LouterDennis A KiesJeanet W BlomGisela M TerwindtGeert J M G van der HeijdenVéronique De GuchtMichel D FerrariWillem J J AssendelftBACKGROUND: The outcome measures most frequently used in studies on the effectiveness of migraine treatment are whether the patient is free of pain, nausea, and free of photophobia/phonophobia within two hours. However, no patient-centred outcome measures are available. Therefore, we performed an online Delphi procedure to compile a list of outcome measures deemed most important to migraine patients. METHODS: From a large database of migraine patients, we randomly selected 150 males and 150 females patients. We asked the open-ended question: 'If a new medicine was developed for migraine attacks, what would you wish the effect of this medication to be?' In the second and third rounds, we presented the answers of the first round and asked the patients to rate the importance of each item. RESULTS: The initial response rate was 56% (n = 169). In the subsequent rounds the response rates were 90% (n = 152), and 97% (n = 147), respectively. Patients wanted their attack medication to treat the headache within 30 min, to prevent the attack from getting worse, to ensure they could function properly within 1 h, and prevent the recurrence of symptoms during the same day. CONCLUSIONS: The currently used outcome measures in migraine research do not sufficiently reflect the wishes of patients. Patients want the medication to work faster, to take away pain at an earlier stage, to make them able to function properly quickly, and to prevent recurrence. These aspects should be considered in future evaluation of new attack medication for migraine.http://europepmc.org/articles/PMC4059644?pdf=render
spellingShingle Antonia F H Smelt
Mark A Louter
Dennis A Kies
Jeanet W Blom
Gisela M Terwindt
Geert J M G van der Heijden
Véronique De Gucht
Michel D Ferrari
Willem J J Assendelft
What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.
PLoS ONE
title What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.
title_full What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.
title_fullStr What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.
title_full_unstemmed What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.
title_short What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.
title_sort what do patients consider to be the most important outcomes for effectiveness studies on migraine treatment results of a delphi study
url http://europepmc.org/articles/PMC4059644?pdf=render
work_keys_str_mv AT antoniafhsmelt whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT markalouter whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT dennisakies whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT jeanetwblom whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT giselamterwindt whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT geertjmgvanderheijden whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT veroniquedegucht whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT micheldferrari whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy
AT willemjjassendelft whatdopatientsconsidertobethemostimportantoutcomesforeffectivenessstudiesonmigrainetreatmentresultsofadelphistudy